Twice a year, people across the UK adjust their clocks, moving between Greenwich Mean Time (GMT) in winter and British Summer Time (BST) during the summer months.

A new one-year trial suggests spectacle lenses designed to soften contrast may slow childhood myopia progression, but the real question is what that means for families in the UK.

A new 12-month trial readout suggests a drug-releasing cataract lens could keep many patients off daily glaucoma drops, raising hopes of longer-lasting pressure control.

A major Phase 3 trial has reported better results than a standard wet-AMD injection, raising hopes for longer-lasting treatment with fewer rescue injections.

The standard treatment for wet age-related macular degeneration (wet AMD) is a relentless cycle.

A major study on instant coffee consumption linked to a significantly greater odds of developing dry age-related macular degeneration (AMD), the main cause of irreversible sight impairment in the UK.

For decades, the root causes of dry age-related macular degeneration have been a black box.

Age-related Macular Degeneration, or AMD, is a name familiar to many, and unfortunately, it stands as a primary cause of significant sight loss, particularly amongst older adults in the developed world.

Bright and dark states of light: Rethinking a fundamental phenomenon

It sounds like something from science fiction, but a team of scientists in the United States has made a rather bold claim: they believe they have experienced a colour previously unseen by human eyes.